Conference Paper
BibTex RIS Cite

Diagnosis of Rheumatic Complications in Patients with Inflammatory Bowel Disease

Year 2020, Volume: 11, 146 - 149, 31.12.2020

Abstract

Investigation methods: X-ray: with a peripheral form without erosive changes; in 15% of patients, erosive changes in the metacarpophalangeal or metatarsophalangeal joints (asymmetry of arthritis). The study of synovial fluid: with a peripheral form, inflammatory in nature. Laboratory studies: increasing the concentration of inflammatory markers, thrombocytosis, anemia of chronic diseases. Diagnostic criteria; - the diagnosis of Ulcerative Colitis or Crohn Disease; - radiological signs of inflammation in the peripheral joints or sacroiliac joints or joints of the spine. Differential diagnosis: - Peripheral form: atypical course of rheumatoid arthritis, infectious arthritis, reactive arthritis; - Axial form: other spondyloarthropathies. Peripheral form: usually has an acute, migratory course; not symmetrical damage to the joints, arthritis of the knee and ankle joints is more often formed; there is no rheumatoid factor; as a rule, there are no erosions and deformations of the joints; most joint changes appear after a few years from the occurrence of inflammatory changes in the intestine. Types of peripheral joint lesions: 1 - oligosarticular (with lesions of ≤5 joints), acute course, can outstrip the appearance of changes in the intestine, usually disappears within 10 weeks, extraintestinal symptoms are often associated, e.g. erythema nodosum; 2 - multi-articular (> 5 joints), usually without connection with the debut of intestinal disease, chronic course (months, years), without extraintestinal symptoms other than uveitis; 3 - peripheral joint damage is combined with axial spondylitis. Axial form: in some patients there is no chronic inflammatory pain in the lower back, despite the presence of radiological changes typical for inflammation of the sacroiliac joints, while in others the characteristic clinical manifestations of spinal lesions occur without typical radiological changes. Changes in other organs associated with Ulcerative Colitis / Crohn Disease.

References

  • Bourikas, L. A., & Papadakis, K. A. (2009). Musculoskeletal manifestations of inflammatory bowel disease. Inflam Bowel Dis, 15, 1915-24.
  • Hindorf, U., Johansson, M., Eriksson, A., et al .(2009). Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Aliment Pharmacol Ther, 29, 654-61.
  • Leclerc-Jacob, S., Lux, G., Rat, A.C., et al .(2014). The prevalence of inflammatory sacroiliitis assessed on magnetic Resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther, 39, 957-62.
  • Mendoza, J.L., Lana, R., Taxonera, C., et al. (2005). Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn’s disease and ulcerative colitis. Med Clin (Barc), 125, 297-300.
  • Orchard T. R., Holt H., Bradbury L., et al. (2009). The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn’s disease. Aliment Pharmacol Ther, 29,193-7.
  • Sulima, O., & Sulyma, V. (2020). The frequency of joints manifestations of inflammatory bowel disease in the practice of a rheumatologist. Abstracts Falk Symposium 218, Mexico. – Р.33.
  • Sulyma, V., & Sulima, O. (2019). The complexity of treatment tactics in patients with severe ulcerative colitis in the presence of extraintestinal manifestations of the joints. Abstracts Falk Symposium 214, Oxford. – P. 81.
Year 2020, Volume: 11, 146 - 149, 31.12.2020

Abstract

References

  • Bourikas, L. A., & Papadakis, K. A. (2009). Musculoskeletal manifestations of inflammatory bowel disease. Inflam Bowel Dis, 15, 1915-24.
  • Hindorf, U., Johansson, M., Eriksson, A., et al .(2009). Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Aliment Pharmacol Ther, 29, 654-61.
  • Leclerc-Jacob, S., Lux, G., Rat, A.C., et al .(2014). The prevalence of inflammatory sacroiliitis assessed on magnetic Resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther, 39, 957-62.
  • Mendoza, J.L., Lana, R., Taxonera, C., et al. (2005). Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn’s disease and ulcerative colitis. Med Clin (Barc), 125, 297-300.
  • Orchard T. R., Holt H., Bradbury L., et al. (2009). The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn’s disease. Aliment Pharmacol Ther, 29,193-7.
  • Sulima, O., & Sulyma, V. (2020). The frequency of joints manifestations of inflammatory bowel disease in the practice of a rheumatologist. Abstracts Falk Symposium 218, Mexico. – Р.33.
  • Sulyma, V., & Sulima, O. (2019). The complexity of treatment tactics in patients with severe ulcerative colitis in the presence of extraintestinal manifestations of the joints. Abstracts Falk Symposium 214, Oxford. – P. 81.
There are 7 citations in total.

Details

Primary Language English
Subjects Engineering
Journal Section Articles
Authors

Olena Sulıma

Volodymyr Sulyma

Publication Date December 31, 2020
Published in Issue Year 2020Volume: 11

Cite

APA Sulıma, O., & Sulyma, V. (2020). Diagnosis of Rheumatic Complications in Patients with Inflammatory Bowel Disease. The Eurasia Proceedings of Science Technology Engineering and Mathematics, 11, 146-149.